Geert Bultynck

34PUBLICATIONS
114CO-AUTHORS
ChemotherapyMolecular targetsElectrometallurgyMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 24, 2026
Cancer-Associated BCL-2 Mutants Reveal Mechanisms Towards Venetoclax Resistance.

|Feb 17, 2026
Anti-apoptotic BCL-2 binds to all three IP3R isoforms, thereby limiting the Ca2+-flux properties of IP3R homo-tetramers.

Ian de Ridder, Claire Cauwelier, Larry E Wagner Ii

|Jan 15, 2026
Inactive ryanodine receptors sustain lysosomal availability for autophagy by promoting ER-lysosomal contact site formation.

Tim Vervliet, Jens Loncke, Marko Sever

|Jun 13, 2025
Endoplasmic reticulum-mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis.

Maria Livia Sassano, Yulia Y Tyurina, Antigoni Diokmetzidou

|Mar 21, 2025
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.

Meike Vogler, Yannick Braun, Victoria M Smith

|Jan 01, 2025
Aspartate signalling drives lung metastasis via alternative translation.

Ginevra Doglioni, Juan Fernández-García, Sebastian Igelmann

Pageof 6

Frequent Collaborators

12 joint publications

Jan B Parys

3 joint publications

Martijn Kerkhofs

3 joint publications

Justin Kale

3 joint publications

Anastassios Economou